Key result
Development of ≥ moderate tricuspid regurgitation after the Ross procedure was associated with a higher rate of post-operative pacemaker implantation.
Why the study?
Risk factors and overall clinical impact of tricuspid regurgitation following the Ross procedure in adults are unknown.
Does the development of ≥ moderate tricuspid regurgitation impact peri-operative and medium-term outcomes in adult patients following the Ross procedure?
Cohort (n=608)
Yes
Does the development of ≥ moderate tricuspid regurgitation impact peri-operative and medium-term outcomes in adult patients following the Ross procedure?
Answers are grounded in this paper and cite their sources.
Post-operative ≥ moderate tricuspid regurgitation occurs in nearly 10% of Ross procedure patients and is associated with longer hospital stays and more pacemaker implantations, but most cases resolve within 1 year without impacting mid-term mortality or reintervention rates.
Structured Abstract Objective Tricuspid regurgitation is a known complication following the Ross procedure in adults. Risk factors and overall clinical impact are unknown. Methods Patients that underwent a Ross procedure at a participating site in the North American Ross Consortium were stratified based on presence of post-operative ≥ moderate TR within the first 30 days post-operatively (1994-2024). Data was analyzed for differences in peri-operative and medium-term outcomes. Results Final cohort size was 608 patients, with 57 (9.4%) developing ≥ moderate TR post-operatively. Patients in the TR group were more likely to be female (54.4% vs. 27.7%, p<0.001), have a history of endocarditis (15.8% vs. 5.2%, p=0.0077), and have had a previous median sternotomy (19.3% vs. 9.1%, p=0.0145). TR patients had longer cardiopulmonary bypass times (227 mins vs. 212 mins, p=0.0084) as well as hospital length of stay (6.0 days vs. 5.0 days, p=0.0018). Rate of post-operative pacemaker implantation was higher in the TR group (8.8% vs. 2.9%, p=0.0395). Early and mid-term mortality did not differ between groups (p=0.4037). There was no difference in valve reintervention rate out to 5 years (p=0.66) and no patients in the TR group required tricuspid valve reintervention. TR resolved to < moderate in 79% of the TR group by 1-year post-operatively. Conclusions Tricuspid regurgitation develops in nearly 10% of patients following the Ross procedure. TR results in longer hospital LOS and higher rate of PPM implantation. There is no difference in mid-term valve reintervention rate or mortality. Most TR resolves within the first post-operative year, supporting conservative therapy.
No takes yet. Share an insight, caveat, or question.
Burke et al. (2026) conducted a cohort in Tricuspid regurgitation following the Ross procedure (n=608). ≥ moderate tricuspid regurgitation vs. < moderate tricuspid regurgitation was evaluated on Post-operative pacemaker implantation (p=0.0395). Development of ≥ moderate tricuspid regurgitation after the Ross procedure was associated with a higher rate of post-operative pacemaker implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: